Mackenzie Financial’s Dynavax Technologies DVAX Stock Holding History

Mackenzie Financial’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,007	Closed	-$99.4K	–	1710
2025 Q3	$99.4K	Hold	10,007	–	–	﹤0.01%	1632
2025 Q2	$99.3K	Hold	10,007	–	–	﹤0.01%	1617
2025 Q1	$130K	Hold	10,007	–	–	﹤0.01%	1569
2024 Q4	$128K	Hold	10,007	–	–	﹤0.01%	1615
2024 Q3	$111K	Buy	+10,007	New	+$110K	﹤0.01%	1468
2022 Q2	–	Sell	-16,190	Closed	-$175K	–	1486
2022 Q1	$175K	Buy	16,190 +3,300	+26%	+$40.1K	﹤0.01%	1311
2021 Q4	$181K	Buy	12,890 +1,947	+18%	+$32K	﹤0.01%	1342
2021 Q3	$210K	Buy	+10,943	New	+$145K	﹤0.01%	1303
2015 Q2	–	Sell	-26,310	Closed	-$590K	–	827
2015 Q1	$590K	Buy	26,310 +4,510	+21%	+$86.4K	﹤0.01%	637
2014 Q4	$368K	Buy	+21,800	New	+$332K	﹤0.01%	672

Other funds holding DVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mackenzie Financial's DVAX Position: Q4 2025 in Review

Mackenzie Financial sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 10,007 shares — an estimated $99.4K sold.

Mackenzie Financial first reported a position in DVAX in Q4 2014 and held it in 10 quarters. The position peaked at $590K in Q1 2015. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

Mackenzie Financial reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
Mackenzie Financial sold 10,007 Dynavax Technologies shares in Q4 2025, an estimated $99.4K.
Mackenzie Financial first reported a position in Dynavax Technologies in Q4 2014 and held it in 10 quarters.
Mackenzie Financial's Dynavax Technologies position peaked at $590K in Q1 2015.
266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Mackenzie Financial's 13F filing for Q4 2025, filed 18 Feb 2026.